Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Dual NK1 and NK2 receptor antagonists under study at Sankyo for respiratory disorders, incontinence

Nov. 20, 1998

Zeneca files sNDA for Accolate asthma therapy

Nov. 20, 1998

ML Laboratories granted second license from U.K. authorities for its dry powder inhaler

Nov. 17, 1998

Novel Astra compounds inhibit mast cell, neutrophil and eosinophil activation

Nov. 16, 1998

New data show rhuMAb-E25 may reduce seasonal allergy symptoms

Nov. 13, 1998

NK2 antagonist from Zeneca blocks increased pulmonary resistance in guinea pigs

Nov. 12, 1998

Cytel's VLA4 antagonist shows potential for treating allergic lung inflammation

Nov. 11, 1998

Pyridyl compounds claimed by Astra for the Rx of asthma and rhinitis

Nov. 11, 1998

Positive phase II results reported for potential asthma treatment

Nov. 11, 1998

Preclinical pharmacokinetics of MEN-11420 determined in rats; compound advances to clinical trials

Nov. 10, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...